These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1124148)

  • 61. Failure to suppress GH secretion after 2 weeks treatment with atropine or propanthelene in diabetics with proliferative retinopathy.
    Hyer SL; Sharp PS; Brooks RA; Burrin JM; Kohner EM
    Acta Endocrinol (Copenh); 1988 Sep; 119(1):61-8. PubMed ID: 3414321
    [TBL] [Abstract][Full Text] [Related]  

  • 62. RETINOPATHY IN WOMEN OVER 45 YEARS OF AGE ATTENDING A DIABETES CLINIC, INCLUDING ITS RELATIONSHIP TO THERAPY WITH SULPHONYLUREAS.
    JACKSON WP; GOLDIN C
    S Afr Med J; 1963 Nov; 37():1225-7. PubMed ID: 14074821
    [No Abstract]   [Full Text] [Related]  

  • 63. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
    Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
    Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme.
    Sjølie AK; Klein R; Porta M; Orchard T; Fuller J; Parving HH; Bilous R; Aldington S; Chaturvedi N
    Diabet Med; 2011 Mar; 28(3):345-51. PubMed ID: 21309844
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Long-term therapy of vascular permeability disorders using anthocyanosides].
    Neumann L
    Munch Med Wochenschr; 1973 May; 115(20):952-4. PubMed ID: 4740456
    [No Abstract]   [Full Text] [Related]  

  • 66. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
    Winneker RC; Parsons JA
    Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
    Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
    Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
    [No Abstract]   [Full Text] [Related]  

  • 68. The natural history of the first clinically visible features of diabetic retinopathy.
    Feman SS
    Trans Am Ophthalmol Soc; 1994; 92():745-73. PubMed ID: 7886883
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diabetic retinopathy. II. Comparison of disease remission induced by various degrees of pituitary ablation by Y90.
    Joplin GF; Oakley NW; Hill DW; Kohner EM; Fraser TR
    Diabetologia; 1967 Aug; 3(4):406-12. PubMed ID: 5620799
    [No Abstract]   [Full Text] [Related]  

  • 70. Progestin-induced growth hormone (GH) production in the treatment of dogs with congenital GH deficiency.
    Kooistra HS; Voorhout G; Selman PJ; Rijnberk A
    Domest Anim Endocrinol; 1998 Mar; 15(2):93-102. PubMed ID: 9532423
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Aspects of growth hormone control in diabetes.
    Hyer SL; Kohner EM
    Aust N Z J Ophthalmol; 1990 Feb; 18(1):33-9. PubMed ID: 2113400
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of growth hormone in the development of diabetic retinopathy.
    Alzaid AA; Dinneen SF; Melton LJ; Rizza RA
    Diabetes Care; 1994 Jun; 17(6):531-4. PubMed ID: 8082520
    [TBL] [Abstract][Full Text] [Related]  

  • 73. OBSERVATIONS OF RETINAL MICROANEURYSMS IN A METAHYPOPHYSEAL DIABETIC CHINESE HAMSTER.
    HAUSLER HR; SIBAY TM; STACHOWSKA B
    Am J Ophthalmol; 1963 Aug; 56():242-4. PubMed ID: 14061601
    [No Abstract]   [Full Text] [Related]  

  • 74. Ticlopidine treatment reduces the progression of nonproliferative diabetic retinopathy. The TIMAD Study Group.
    Arch Ophthalmol; 1990 Nov; 108(11):1577-83. PubMed ID: 2244843
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Contribution to the treatment of retinal hemorrhages based on diseases of the retinal vessels in diabetes and hypertension].
    STREITENBERG H
    Klin Monbl Augenheilkd; 1963 Jun; 142():895-7. PubMed ID: 13978840
    [No Abstract]   [Full Text] [Related]  

  • 76. DIABETIC RETINOPATHY. DIAGNOSIS AND PATHOLOGY.
    SULLIVAN JJ
    N Y State J Med; 1963 Oct; 63():2790-1. PubMed ID: 14076784
    [No Abstract]   [Full Text] [Related]  

  • 77. [Indications and results of interstitial hypophyseal stereo-gammatherapy in the treatment of diabetic retinopathy].
    Debry G; Schaub C; Drouin P; Szikla G; Talairach J
    Neurochirurgie; 1977 Mar; 23(1):3-20. PubMed ID: 339116
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Retinopathy and plasma growth hormone levels in idiopathic hemochromatosis with diabetes.
    Passa P; Rousselie F; Gauville C; Canivet J
    Diabetes; 1977 Feb; 26(2):113-20. PubMed ID: 838164
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A pilot clinical study on the effectiveness of mesoglycan against diabetic retinopathy.
    Pacella E; Pacella F; Turchetti P; Mazzeo F; Anzidei R; Malvasi A; Malarska KG; Brillante C; Balocco Gabrieli C
    Clin Ter; 2012; 163(1):19-22. PubMed ID: 22362228
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PITUITARY STALK SECTION IN TREATING ADVANCED DIABETIC RETINOPATHY.
    FLOHR LJ; MAXWELL HW
    Tex State J Med; 1963 Nov; 59():1091-4. PubMed ID: 14084905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.